-
Prolia®
When bones become fragile, even minor falls or everyday movements can lead to fractures, pain, and long-term complications. At Singlepoint Healthcare, we offer Prolia® therapy as part of a comprehensive approach to protecting bone strength, reducing fracture risk, and helping patients maintain an active, confident lifestyle.
How Prolia® Works
Bone health is vital to mobility, independence, and overall quality of life, especially as we age or manage chronic conditions that reduce bone density.
Prolia® (denosumab) is a prescription medication used to treat osteoporosis and other conditions associated with bone loss. It works by targeting a specific pathway involved in bone breakdown, helping slow bone resorption while supporting stronger, denser bones over time.
Key Details
Important Information
| Category | Details |
|---|---|
| Conditions It Treats | Osteoporosis, Postmenopausal osteoporosis, Glucocorticoid-induced osteoporosis (GIOP) |
| Manufacturer | Amgen |
| Administered by | Injection |
| Frequency | Every 6 months |
| FDA Approval(s) | Osteoporosis: September 2012 Postmenopausal osteoporosis: June 1, 2010 Glucocorticoid-induced osteoporosis (GIOP): May 2018 |